Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Biomarin Pharmaceuticals
(NQ:
BMRN
)
79.17
USD
UNCHANGED
Streaming Delayed Price
Updated: 7:55 PM EST, Mar 1, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
78.70 (5)
Ask (Size)
79.75 (1)
Prev. Close
79.17
Today's Range
79.17 - 79.17
52wk Range
68.25 - 131.94
Shares Outstanding
176,713,314
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
BioMarin Announces Fourth Quarter and Record Full-year 2020 Financial Results and Corporate Updates
February 25, 2021
- Full-year 2020 Total Revenues Increased 9% to $1.86 billion
From
PR Newswire
BioMarin to Participate in Four Upcoming Virtual Investor Conferences
February 24, 2021
- 2021 SVB Leerink Global Healthcare Conference on February 26 at 11:20am ET
From
PR Newswire
Performance
YTD
-8.26%
-8.26%
1 Month
-4.61%
-4.61%
3 Month
+0.60%
+0.60%
6 Month
+1.46%
+1.46%
1 Year
-16.13%
-16.13%
More News
Read More
BioMarin Appoints Former Goldman Sachs Partner and Life Sciences Executive, Maykin Ho, Ph.D. to Board of Directors
February 18, 2021
From
PR Newswire
BioMarin Earns Top Marks in Human Rights Campaign's 2021 Corporate Equality Index
January 28, 2021
From
PR Newswire
BioMarin to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, February 25 at 4:30pm ET
January 26, 2021
From
PR Newswire
BioMarin Announces Positive Phase 3 Gene Therapy Trial Results in Adults with Severe Hemophilia A; Study Met All Primary and Secondary Efficacy Endpoints in One-Year Data Set
January 10, 2021
From
PR Newswire
Noteworthy Friday Option Activity: BMRN, ZNGA, ZYXI
February 26, 2021
Tags
Stocks
From
Market News Video
BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN
February 26, 2021
From
PR Newswire
Biomarin Pharmaceutical Inc (BMRN) Q4 2020 Earnings Call Transcript
February 26, 2021
Tags
BMRN
Market News
From
Motley Fool
Implied USMV Analyst Target Price: $73
January 28, 2021
Tags
ETFs
From
ETF Channel
Is Pfizer Stock A Buy On Guidance For $15 Billion In Covid Vaccine Sales?
February 02, 2021
From
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.